Executive Vice President, Emeritus, and Distinguished Research Fellow at ImmunoGen, Inc.
Dr. Lambert earned a Ph.D. in Biochemistry (1976) from University of Cambridge (England, UK), under the supervision of Professor Richard N. Perham. His postdoctoral training was at the University of California, Davis, working on ribosome structure in the laboratory of Dr Robert R Traut (1976-1980), and at the University of Glasgow, Scotland working on the arom multienzyme complex with Dr John R Coggins (1980-1982). In 1982, Dr. Lambert joined the Dana-Farber Cancer Institute, Harvard Medical School, working on the ImmunoGen-funded programs to develop antibody-drug conjugates (ADCs) and immunotoxins as anti-cancer therapeutics. Dr. Lambert joined ImmunoGen in 1987 when the company established independent research laboratories in Cambridge, Massachusetts. After working in a variety of roles at the company, Dr. Lambert served as Chief Scientific Officer from 2008 until 2015 at which time he was appointed Distinguished Research Fellow. He also served on the executive committee as Executive Vice President, Research, from 2008 until 2017. Dr. Lambert currently has an Emeritus position on the executive committee of ImmunoGen. He is the author/co-author of over 120 peer-reviewed scientific publications. In 2016, Dr Lambert was elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).